IJMS, Vol. 25, Pages 4411: Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold

IJMS, Vol. 25, Pages 4411: Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold

International Journal of Molecular Sciences doi: 10.3390/ijms25084411

Authors: Xingyi Li Jun Hao Junming Li Zhelin Zhao Xuequn Shang Min Li

The pathogenesis of carcinoma is believed to come from the combined effect of polygenic variation, and the initiation and progression of malignant tumors are closely related to the dysregulation of biological pathways. Quantifying the alteration in pathway activation and identifying coordinated patterns of pathway dysfunction are the imperative part of understanding the malignancy process and distinguishing different tumor stages or clinical outcomes of individual patients. In this study, we have conducted in silico pathway activation analysis using Riemannian manifold (RiePath) toward pan-cancer personalized characterization, which is the first attempt to apply the Riemannian manifold theory to measure the extent of pathway dysregulation in individual patient on the tangent space of the Riemannian manifold. RiePath effectively integrates pathway and gene expression information, not only generating a relatively low-dimensional and biologically relevant representation, but also identifying a robust panel of biologically meaningful pathway signatures as biomarkers. The pan-cancer analysis across 16 cancer types reveals the capability of RiePath to evaluate pathway activation accurately and identify clinical outcome-related pathways. We believe that RiePath has the potential to provide new prospects in understanding the molecular mechanisms of complex diseases and may find broader applications in predicting biomarkers for other intricate diseases.